Rationale, Design, and Baseline Characteristics of a Trial Comparing Aggressive Lipid Lowering With Atorvastatin Versus Revascularization Treatments (AVERT)
Lisa S. McCormick PharmD, Donald M. Black MD, David Waters MD, W.Virgil Brown MD, Bertram Pitt MDVolume:
80
Year:
1997
Language:
english
Pages:
4
DOI:
10.1016/s0002-9149(97)00627-9
File:
PDF, 123 KB
english, 1997